Virtu Financial

8-KPositiveEarnings
Filed Nov 5
Market Making drove 39.9% Y/Y revenue growth; planned Delaware-to-Texas reincorporation aligns with a key trading hub.
8-KLeadership change
Filed Aug 21
Fuze Health legal chief Barbara Finigan joins as an independent director, expanding the board to 11 members.
10-QQ2 FY2026
Filed Jul 31
Higher trading volumes fueled Market Making growth, but incentive accruals and trading costs kept common-stockholder earnings broadly flat.
- Revenue—
- Net income$150.9MYoY −0.2%
8-KPositiveEarnings
Filed Jul 30
Market Making trading gains lifted revenue, but higher compensation and trading costs pushed net income lower.
8-KDebt financing
Filed Jul 23
Closed $500M of first-lien term B-2 loans for general corporate purposes, lifting the term B-2 balance to $2.03B.
8-KPositiveEarnings
Filed Jul 14
Markets a $400M Term Loan B add-on for general corporate purposes; preliminary trading income rises while net income edges lower.
8-KShareholder vote
Filed Jun 10
Stockholders elected Aaron Simons, Joseph J. Grano, Jr. and Joanne M. Minieri to Class II board seats through 2029 and approved executive pay.
8-KExecutive pay
Filed Jun 9
CFO Cindy Lee’s amended agreement sets a $0.5M base salary and adds a special award of 20,000 restricted shares or RSUs.

Coverage: 10-K, 10-Q and 8-K filings filed since Jun 1, 2026.

8-KPositiveEarnings